Healthcare Sales & Marketing Network: Interventional Cardiology : Medical Device and Pharmaceutical News

Healthcare News Roundup: Interventional Cardiology

HSMN NewsFeed - 12 Jul 2013
Boston Scientific Launches Guidezilla(TM) Guide Extension Catheter in U.S. and Europe
Devices Interventional Cardiology FDA Product Launch

HSMN NewsFeed - 10 Jul 2013
STENTYS Self-Apposing Stent Approved in Europe for Additional Coronary Indications
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 10 Jul 2013
Abbott Announces Approval of Next-Generation XIENCE Xpedition(TM) Drug Eluting Stent System in Japan
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 19 Jun 2013
AngioScore Announces Completion of Enrollment in Drug-Coated AngioSculpt(R) Scoring Balloon Catheter First-in-Human Study
Devices Interventional Cardiology

HSMN NewsFeed - 30 May 2013
Orsiro From BIOTRONIK, Industry's First Hybrid Drug-Eluting Stent, Performs as Best in Class
Devices Interventional Cardiology

HSMN NewsFeed - 28 May 2013
RenalGuard Therapy(R) Shows Promise in TAVI Procedures
Devices Interventional Cardiology

HSMN NewsFeed - 27 May 2013
OrbusNeich Launches World's First Dual Therapy Stent That Addresses Challenges of Delayed Coronary Artery Healing Associated with Monotherapy Drug Eluting Stents
Devices Interventional Cardiology Product Launch

HSMN NewsFeed - 24 May 2013
Elixir Medical Corporation Announces Outstanding Two-Year Results from the EXCELLA BD Randomized Clinical Trial for the CE Mark-Approved DESyne(R) BD System with Biodegradable Polymer Coating
Devices Interventional Cardiology

HSMN NewsFeed - 23 May 2013
Svelte Drug-Eluting Stent Utilizing New Class of Bioabsorbable Drug Coating Attains 0% Clinically-Driven Events Through 12-Months in First-In-Man Study
Devices Interventional Cardiology

HSMN NewsFeed - 23 May 2013
InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group
Devices Interventional Cardiology

HSMN NewsFeed - 22 May 2013
Boston Scientific Promus PREMIER(TM) and SYNERGY(TM) Drug-Eluting Stent Systems Provide Exceptional Safety and Efficacy Data
Devices Interventional Cardiology

HSMN NewsFeed - 22 May 2013
OrbusNeich's Genous(TM) Stent Associated With Lower Restenosis Rate Compared to Bare Metal Stents in Low-Risk Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Patients
Devices Interventional Cardiology

HSMN NewsFeed - 21 May 2013
Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 21 May 2013
Registry Data Presented at EuroPCR 2013 Confirms the Neovasc Reducer(TM) Improves Cardiovascular Parameters in Refractory Angina Patients
Devices Interventional Cardiology

HSMN NewsFeed - 21 May 2013
OrbusNeich seizes Boston Scientific stents in Germany as part of patent infringement proceedings
Devices Interventional Cardiology Litigation

HSMN NewsFeed - 20 May 2013
OrbusNeich's Genous(TM) Stent Associated With Lower Restenosis Rate Compared to Bare Metal Stents in Low-Risk Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Patients
Devices Interventional Cardiology

HSMN NewsFeed - 20 May 2013
Claret Medical, Inc. Announces Publication of the First Clinical Research on the Frequency and Composition of Embolic Debris Captured during TAVR
Devices Interventional Cardiology

Older Interventional Cardiology stories Return to NewsFeed

FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!